The present invention encompasses compounds of general formula (I)
wherein the groups R
5
to R
10
, A, L
1
, B, m and p are defined as in claim
1
, which are suitable for the treatment of diseases characterised by excessive or abnormal cell proliferation, pharmaceutical preparations which contain such compounds and their use as medicaments.